Alba A, Trainor FS et al.: A clinical disability rating scale for Parkinson patients. J Chron Dis, 21:507, 1968.
Brown RG, MacCarthney B et al.: Accuracy of self reported disability in patients with parkinsonism.
Arch Neurol, 46:955, 1989.
Canter CJ, de la Torre R, Mier M: A method of evaluating disability in patients with Parkinson’s disease. J Nerv Ment Dis, 133:143, 1961.
Chouinard G, Ross-Chouinard M: Ethoprazine and benztropine in neuroleptic-induced parkinsonism.
J Clin Psychiat, 40:73, 1979.
Crane GE, Ruiz P et al.: Effects of drug withdrawal on tardive dyskinesia. Act Nerv Sup, 11:30, 1969.
Fahn S, Elton RL and Members of the UPRDS Development Committee: Unified Parkinson’s Disease Rating Scale. In: Fahn S et al. (Eds.) "Recent Development in Parkinson’s Disease II", MacMillan, New Yok, 1987.
Guy W: ECDEU Assessment Manual for Psychopharmacology. Revised, 1976. DHEW Publication No. (ADM) 76-338, 1976.
Harcherik DF, Leckman JF et al.: A new instrument for clinical studies on Tourette’s syndrome. J Am Acad Child Psychiatry, 23:153, 1984.
Hoehn MM, Yahr MD: Parkinsonism: Onset, progression, and mortality. Neurology, 17:427, 1967.
Larsen TA, Calne S, Calne DB: Assessment of Parkinson’s disease. Clin Neuropharmacol, 7:165, 1984.
Lieberman AN: Parkinson’s disease: a clinical review. Am J Med Sci, 267:66, 1974.
Marilla RJ, Rinne UK: Disability and progression in Parkinson’s disease. Acta Neurol Scand, 56:159, 1977.
McDowell F, Lee JE et al.: Treatment of Parkinson’s syndrome with L Dihydroxyphenilalanine (Levodopa). Ann Intern Med, 72:29, 1970.
Montgomery GK, Reynolds C, Warren RM: Qualitative assessmentof Parkinson’s disease: Study of reliability and data reduction with an abbreviated Columbia Scale. Clin Neuropharmacol, 8:83, 1985.
Reda FA, Scanlon JM et al.: Treatment of tardive dyskinesia with lithium carbonate. N Engl J Med, 291: 850, 1974.
Schwab RS: Progression and prognosis in Parkinson’s disease. J Nerv Ment Dis, 130:556, 1960.
Schwab RS, England AC: Projection technique for evaluating surgery in Parkinson’s disease. In:
Gillingham FJ, Donaldson MC (Eds.) "Third Symposium on Parkinson’s Disease", ES Livingstone, Edimburg, 1969.
Simpson GM, Angus JWS: A rating scale for extrapyramidal side effects. Acta Psychiat Scan, 45(s):11, 1970.
Simpson GM, Lee JH et al.: A rating scale for tardive dyskinesia. Psychopharmacology, 64:171, 1979.
Smith RC, Tamminga CA et al.: Effects of dopamine agonists in tardive dyskinesia. Am J Psychiatry, 134:763, 1977.
Webster DD: Critical analysis of the disability in Parkinson’s disease. Mod Treat, 5:257, 1968.
